SentiMag® Intraoperative Comparison in Breast Cancer
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this pivotal study is to provide prospective evidence that the
SentiMag®/SiennaXP® is safe and non-inferior to the current standard of care for lymph node
localization in patients with breast cancer as part of a sentinel lymph node biopsy (SLNB)
procedure and to summarize measures of product safety and performance.